Bioharvest Sciences Inc. (Nasdaq: BHST), an SEC filer in Pharmaceutical Preparations, closed at $1.84, -0.5%, on 2026-08-28, with a market cap of $42M as of 2026-08-27, a return on equity of -83.2% and a net margin of -32.3%. Institutional ownership, earnings history and filed financials are on the tabs below.
Returns use ADJUSTED closes (splits + dividends).
Volume as VALUE TRADED — close × volume, in USD.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | BHST | SPY | Δ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 · ytd | −5.4% | −4.1% | −7.9% | −3.0% | −8.3% | −25.9% | −24.5% | −14.8% | — | — | — | — | −64.5% | +13.4% | −78.0pp |
| 2025 | −19.7% | +5.7% | +18.1% | +4.0% | −2.7% | +7.5% | +12.9% | +7.6% | +15.0% | −4.9% | −24.8% | −22.9% | −16.0% | +17.7% | −33.7pp |
| 2024 · part | — | — | — | — | — | — | — | — | — | — | — | +0.5% | +0.5% | +24.9% | −24.4pp |
Month-end over prior month-end; a blank cell is no return.
Basis. Both columns share one basis, so Δ is like-for-like.
End-of-day closes; a “ytd” or “part” year is not a full year.
| Month | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ⓘ | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 |
| Positive ⓘ | 0% | 50% | 50% | 50% | 0% | 50% | 50% | 50% | 100% | 0% | 0% | 50% |
| Median | −12.6% | +0.8% | +5.1% | +0.5% | −5.5% | −9.2% | −5.8% | −3.6% | +15.0% | −4.9% | −24.8% | −11.2% |
| Best | −5.4% | +5.7% | +18.1% | +4.0% | −2.7% | +7.5% | +12.9% | +7.6% | +15.0% | −4.9% | −24.8% | +0.5% |
| Worst | −19.7% | −4.1% | −7.9% | −3.0% | −8.3% | −25.9% | −24.5% | −14.8% | +15.0% | −4.9% | −24.8% | −22.9% |
| vs SPY ⓘ | −14.6pp | +1.9pp | +10.4pp | −4.3pp | −11.3pp | −11.3pp | −6.9pp | −6.1pp | +11.5pp | −7.3pp | −25.0pp | −10.0pp |
21 monthly observations · 2024–2026 · benchmark SPY
